Global Oral Solid Dosage Manufacturing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Oral Solid Dosage Manufacturing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Oral solid dosage manufacturing refers to the process of producing pharmaceutical products in solid form that are intended to be taken orally, such as tablets, capsules, and powders. This manufacturing process involves several steps, including formulation development, blending, granulation, compression, coating, and packaging.
Formulation development is the initial stage where the active pharmaceutical ingredient (API) and other excipients are selected and combined to create a stable and effective dosage form. Blending involves mixing the API and excipients to ensure uniform distribution of the drug throughout the dosage form. Granulation is the process of forming granules from the blended mixture to improve flowability and compressibility.
Compression is the step where the granules are compressed into tablets or filled into capsules using specialized equipment. Coating may be applied to tablets to improve appearance, taste, and stability, as well as to control the release of the drug. Finally, the finished dosage forms are packaged in appropriate containers, such as blister packs or bottles, and labeled for distribution.
Oral solid dosage manufacturing requires strict adherence to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the pharmaceutical products. This includes maintaining a controlled manufacturing environment, conducting regular quality control testing, and following standard operating procedures to prevent contamination and ensure consistency in the manufacturing process.
This report is a detailed and comprehensive analysis for global Oral Solid Dosage Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Solid Dosage Manufacturing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage Manufacturing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Solid Dosage Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Solid Dosage Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, Alcami, Thermo Fisher Scientific, Recipharm, Metrics Contract Services, BOC Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oral Solid Dosage Manufacturing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Wet Granulation
Dry Granulation
Direct Compression
Particle Coating
Other
Market segment by Application
Drug Formulation Development
Formulation Production
Market segment by players, this report covers
CRB
LGM Pharma
Pfizer
Piramal Group
Avara Pharmaceutical Services
Alcami
Thermo Fisher Scientific
Recipharm
Metrics Contract Services
BOC Sciences
Societal CDMO
DFE Pharma
NNE
Pharma Access
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Solid Dosage Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Solid Dosage Manufacturing, with revenue, gross margin, and global market share of Oral Solid Dosage Manufacturing from 2020 to 2025.
Chapter 3, the Oral Solid Dosage Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oral Solid Dosage Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Solid Dosage Manufacturing.
Chapter 13, to describe Oral Solid Dosage Manufacturing research findings and conclusion.
Oral solid dosage manufacturing refers to the process of producing pharmaceutical products in solid form that are intended to be taken orally, such as tablets, capsules, and powders. This manufacturing process involves several steps, including formulation development, blending, granulation, compression, coating, and packaging.
Formulation development is the initial stage where the active pharmaceutical ingredient (API) and other excipients are selected and combined to create a stable and effective dosage form. Blending involves mixing the API and excipients to ensure uniform distribution of the drug throughout the dosage form. Granulation is the process of forming granules from the blended mixture to improve flowability and compressibility.
Compression is the step where the granules are compressed into tablets or filled into capsules using specialized equipment. Coating may be applied to tablets to improve appearance, taste, and stability, as well as to control the release of the drug. Finally, the finished dosage forms are packaged in appropriate containers, such as blister packs or bottles, and labeled for distribution.
Oral solid dosage manufacturing requires strict adherence to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the pharmaceutical products. This includes maintaining a controlled manufacturing environment, conducting regular quality control testing, and following standard operating procedures to prevent contamination and ensure consistency in the manufacturing process.
This report is a detailed and comprehensive analysis for global Oral Solid Dosage Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Solid Dosage Manufacturing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage Manufacturing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Solid Dosage Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Solid Dosage Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, Alcami, Thermo Fisher Scientific, Recipharm, Metrics Contract Services, BOC Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oral Solid Dosage Manufacturing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Wet Granulation
Dry Granulation
Direct Compression
Particle Coating
Other
Market segment by Application
Drug Formulation Development
Formulation Production
Market segment by players, this report covers
CRB
LGM Pharma
Pfizer
Piramal Group
Avara Pharmaceutical Services
Alcami
Thermo Fisher Scientific
Recipharm
Metrics Contract Services
BOC Sciences
Societal CDMO
DFE Pharma
NNE
Pharma Access
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Solid Dosage Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Solid Dosage Manufacturing, with revenue, gross margin, and global market share of Oral Solid Dosage Manufacturing from 2020 to 2025.
Chapter 3, the Oral Solid Dosage Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oral Solid Dosage Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Solid Dosage Manufacturing.
Chapter 13, to describe Oral Solid Dosage Manufacturing research findings and conclusion.
Table of Contents
119 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
